The number of Kovid-19 cases approached 25 million in India

class = “cf”>

According to the statement from the Ministry of Health of India, 281 thousand 386 new cases of Kovid-19 have been detected in the last 24 hours, 4 thousand 106 people have died due to the virus.

The total number of cases in India increased to 24 million 965,000 463 and the total number of victims to 274,000 390.

Experts warn that the actual number of cases and deaths may be much higher than expected.

The treatment of 3 million 516 thousand 997 patients continues in the country.

The daily number of cases in India fell below 300,000 for the first time since April 21.

The number of daily victims of Kovid-19 is more than 3 thousand since April 27 in the country.

The Indian Ministry of Health announced yesterday that the situation in the country affected by the second wave of the epidemic had stabilized.

Meanwhile, the police investigation into hundreds of corpses found on the Ganges in the states of Bihar and Uttar Pradesh, believed to belong to Kovid-19 patients, continues.


class = “cf”>

Although around 182 million 926 thousand 460 doses of vaccines have been delivered since January 16, the date of the launch of the vaccination campaign in India, whose population is approaching 1.4 billion, the campaign has not reached the level to stop the epidemic.

Adar Poonawalla, CEO of the Serum Institute of India (SII), the world’s largest vaccine maker, warned in an interview with the Financial Times that there was a vaccine shortage and that it would take a few months.

The fact that the institute, which has a production agreement with AstraZeneca and is committed to producing vaccines for the World Health Organization’s (WHO) Kovid-19 vaccine access program, must meet the urgent domestic demand, which can negatively affect the supply of vaccines in the world.

The United States, Britain, Germany and other countries have stepped up the export of drugs, test kits and oxygen therapy to India, as well as substances used in vaccine production.

The US Embassy in New Delhi Chargé d’Affaires Dabiel B. Smith announced that vaccine components delivered to the country will help produce 20 million AstaZeneca vaccines.

Poonawalla called on US President Joe Biden to lift the embargo on certain raw materials needed for vaccine production.

The United States has raised the waiver of intellectual property rights on Kovid-19 vaccines to support vaccine production. It is believed that such a step will facilitate vaccine production in India.

Bigpara for cryptocurrency markets

Bigpara for cryptocurrency markets

Add a Comment